Case series to study the clinical features, risk factors, prognostic factors, and to assess the different management modalities of EPN and its outcomes

Udit Jain; Yashwanth Kumar Gaddam; Sreedhar Dayapule; Dinesh Kumar Ravi

doi:10.18203/2320-6012.ijrms20240536

Authors

Udit Jain Department of Urology, Narayana Medical College, Nellore, Andhra Pradesh, India
Yashwanth Kumar Gaddam Department of Urology, Narayana Medical College, Nellore, Andhra Pradesh, India
Sreedhar Dayapule Department of Urology, Narayana Medical College, Nellore, Andhra Pradesh, India
Dinesh Kumar Ravi Department of Urology, Narayana Medical College, Nellore, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20240536

Keywords:

Double J stenting, Emphysematous pyelonephritis, Nephrectomy, PCN

Abstract

Background: Emphysematous pyelonephritis is an acute necrotising infection of the kidney, often associated with high rate of renal loss and mortality. EPN mostly present with triad of fever, flank pain and nausea. The diagnostic tool of choice is CT KUB. E. coli is the most common pathogen.

Methods: It was prospective study done on 52 patients who were diagnosed to have EPN from department of nephrology and urology in Narayana Medical College, Nellore from March 2022 to January 2024. The diagnosis of EPN was confirmed by plain CT KUB scan.

Results: Among 52 patients 48 patients had diabetes mellitus (DM). left kidney involved in 28 patients and right kidney involved in 16 patients and bilateral kidney involvement in 8. Fever (92%), flank pain (88%) are the most common presentation in patients. Shock during initial presentation was seen in 19.5% of patients. E. coli growth was seen in 26.9% cases. 8 patients were treated conservatively with antibiotics according to culture and sensitivity. 32 patients required double J stenting, 7 patients required percutaneous nephrostomy. Nephrectomy was done in 5 patients. Mortality rate in our study was zero.

Conclusions: Nephrectomy should be promptly attempted for patients not responding to conservative methods. Pre-existing CKD status, shock at presentation and altered sensorium are the factors determining the prognosis and management.

Metrics

Metrics Loading ...

References

Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997;49:343-6.

Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001;34:125-30.

Misgar RA, Mubarik I, Wani AI, Bashir MI, Ramzan M, Laway BA. Emphysematous pyelonephritis: a 10-year experience with 26 cases. Indian J Endocrinol Metab. 2016;20(4):475-80.

Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D. Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol. 2009;41:959-66.

Boakes E, Batura D. Deriving a management algorithm for emphysematous pyelonephritis: can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy? Int Urol Nephrol. 2017;49(12):2127-36.

Sokhal AK, Kumar M, Purkait B, Jhanwar A, Singh K, Bansal A, et al. Emphysematous pyelonephritis: Changing trend of clinical spectrum, pathogenesis, management and outcome. Turk J Urol. 2017;43(2):202.

Schultz EH, Klorfein EH. Emphysematous Pyelonephritis. J Uro. 1962;87762-66.

Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986-9.

Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in emphysematous pyelonephritis. J Urol. 1998;159(2):369-73. doi:10.1016/s0022-5347(01)63919-3.

Torres H, Sharma P. Bilateral emphysematous pyelonephritis. Urol Case Rep. 2018;17:119-21.

Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997;49(3):343-6.

Lu YC, Chiang BJ, Pong YH, Chen CH, Pu YS, Hsueh PR, et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol. 2014;21(3):277-82.

Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classiﬁcation, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160:797-805.

Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors for mortality in patients with emphysematous pyelo-nephritis: a metaanalysis. J Urol. 2007;178:880-5.

Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: time for a management plan with an evidence-based approach. Arab J Urol. 2014;12:106-15.

Dunn SR, Dewolf WC, Gonzalez R. Emphysematous pyelonephritis: report of 3 cases treated by nephrectomy. J Urol. 1975;114:348‑50.

Cook DJ, Achong MR, Dobranowski J. Emphysematous pyelonephritis. Complicated urinary tract infection in diabetes. Diabetes Care. 1989;12:229‑32.

Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, et al. Emphysematous pyelonephritis: a 5‑year experience with 13 patients. J Urol. 1985;134:1086‑8.

Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105:986‑9.